The oral contraceptive pill is known to reduce the risk of sporadic endometrial and ovarian cancer,24, 25 as well as BRCA1/2‐associated ovarian cancer,26 and the levonorgestrel‐releasing intrauterine system reduces the risk of endometrial cancer in the general population.27 Here, BRCA1 is linked to ovarian carcinoma.